Groundbreaking Phase 3 Trial Shows Promise of Gotistobart Immunotherapy for Lung Cancer Florida Cancer Specialists' Phase 3 trial reveals that Gotistobart, a new immunotherapy, may improve outcomes for advanced lung cancer patients with fewer side effects.

Groundbreaking Phase 3 Trial Shows Promise of Gotistobart Immunotherapy for Lung Cancer #United_States #Florida_Cancer_Specialists #Fort_Myers #Lung_Cancer #Gotistobart

Growth Insights on the Global Lung Cancer Surgery Market Driven by Precision Oncology The global lung cancer surgery market is projected to expand at a 5.9% CAGR, driven by increased adoption of robotic and minimally invasive techniques. Key players Medtronic and Intuitive Surgical lead this growth.

Growth Insights on the Global Lung Cancer Surgery Market Driven by Precision Oncology #None #Medtronic #Lung_Cancer #Intuitive_Surgical

Overcoming Fear, Embracing Change: Linda Kneidegger’s Journey from Athlete to Resilient Coach In this engaging interview, Linda Kneidinger shares her journey from sports psychology to coaching, emphasizing the power of mindset, neuroplasticity, and facing fears like skydiving to build trust and resilience. Discover practical neuroscience insights and actionable strategies to enhance personal growth and well-being. Key Topics - The role of neuroplasticity in personal growth - Using fear as a tool for trust and resilience - The importance of mindset in health outcomes Takeaways Facing fears like skydiving can build trust and resilience. Understanding neuroplasticity helps rewire the brain for positive change. A positive mindset can influence health outcomes and recovery. Sound Bites "It's perfectly safe, but it's not meant for me." "A positive mindset influences health outcomes." "Create new experiences to slow down time."  resources About Linda Kneidinger Linda Kneidinger is a Personal Coach, Author, and Speaker with a Neuroscience degree from the University of Pennsylvania and two Master's degrees in Psychology. With 30 years of experience helping professionals, executives, and athletes master their mindset, Linda is the founder of Ultimate You Coaching and creator of the Anxious Mouse Method — a practical approach to quieting the mental chatter that holds people back. Her book Your Best Year Yet is available on Amazon now. Find out more at lindakneidinger.com https://lindakneidinger.com/ https://www.ultimateyou-coaching.com/ https://a.co/d/0fCpQWWT linda@ultimateyou-coaching.com https://bookme.name/PhilippaBagley/lite/system-reset-session I'm a Clinical Hypnotherapist, MSc Neuroscience & Psychology of Mental Health student at King's College London, Army Veteran, and Programme Manager in my day job. Like many high-achieving professionals, I know what it's like to keep pushing through exhaustion — running on empty while everything looks fine on the outside. Now I combine my neuroscience training, clinical hypnotherapy practice, and lived experience of high-pressure environments to help ambitious professionals do one thing: actually recover. My specialist focus is burnout and sleep regulation for high-achievers — the people who can't switch off, can't sleep, and have tried everything except getting to the root cause. Through Choose2Change, I work with professionals in corporate, NHS, legal, tech, and military environments who are ready to regulate their nervous system and reclaim their energy — without burning it all down first. If that sounds like you — or someone you know — a free 20-minute Sleep & Burnout Clarity Call is available athttps://bookme.name/PhilippaBagley/lite/system-reset-session Journey to Purpose explores what drives people, the stories behind their careers, and what it really means to live and work with intention.

📣 New Podcast! "Overcoming Fear, Embracing Change: Linda Kneidegger’s Journey from Athlete to Resilient Coach" on @Spreaker #cancer #career #coaching #facing #fear #health #life_transformation #lung_cancer #mental_resilience #mindset #neuroplasticity #neuroscience #overcoming #personal_growth

Revolutionizing Lung Cancer Diagnosis: The Cost-Effectiveness of Optellum's AI Risk Stratification A recent study highlights the cost-effectiveness of Optellum's AI for lung nodule risk stratification, proving essential in early lung cancer diagnosis.

Revolutionizing Lung Cancer Diagnosis: The Cost-Effectiveness of Optellum's AI Risk Stratification #USA #AI #Houston #Lung_Cancer #Optellum

Coreline Soft's AI Lung Cancer Screening Solution Now at Charité Berlin Coreline Soft has launched its AI-assisted lung cancer screening solution at Charité in Berlin, aiming to revolutionize national health standards.

Coreline Soft's AI Lung Cancer Screening Solution Now at Charité Berlin #Germany #Berlin #Lung_Cancer #Coreline_Soft #Charité_Berlin

Caris Life Sciences Unveils New Study Enhancing Cancer Diagnosis with AI Algorithm GPSai Caris Life Sciences has introduced a groundbreaking study highlighting the role of GPSai technology in improving the accuracy of cancer diagnoses, particularly for lung squamous cell carcinoma.

Caris Life Sciences Unveils New Study Enhancing Cancer Diagnosis with AI Algorithm GPSai #USA #Caris_Life_Sciences #Irving #Lung_Cancer #GPSai

SystImmune to Unveil Promising Data on iza-bren for Small Cell Lung Cancer at ELCC 2026 SystImmune, Inc. is set to present new findings on iza-bren, an innovative treatment for extensive stage small cell lung cancer at ELCC 2026.

SystImmune to Unveil Promising Data on iza-bren for Small Cell Lung Cancer at ELCC 2026 #United_States #SystImmune #Redmond #Lung_Cancer #Iza-bren

Kelun-Biotech to Unveil Final Analysis of Sacituzumab Tirumotecan at ELCC 2026 At the 2026 European Lung Cancer Congress, Kelun-Biotech will present pivotal data on sacituzumab tirumotecan, showcasing its effectiveness in treating advanced lung cancer.

Kelun-Biotech to Unveil Final Analysis of Sacituzumab Tirumotecan at ELCC 2026 #Denmark #Copenhagen #Kelun-Biotech #Lung_Cancer #sacituzumab_tirumotecan

Freenome Unveils Promising Data for Innovative Lung Cancer Blood Test Freenome has presented early data for a blood-based lung cancer screening test, showing high sensitivity and promise for detecting cancer in at-risk populations.

Freenome Unveils Promising Data for Innovative Lung Cancer Blood Test #None #California #Lung_Cancer #Blood_Test #Freenome

Genprex's Reqorsa® Gene Therapy Shows Promise for Lung Cancer in Upcoming AACR 2026 Presentation Genprex, Inc. plans to showcase encouraging preclinical findings on Reqorsa®, a gene therapy for lung cancer, at AACR 2026. Key biomarkers related to therapy response will be discussed.

Genprex's Reqorsa® Gene Therapy Shows Promise for Lung Cancer in Upcoming AACR 2026 Presentation #United_States #San_Diego #Lung_Cancer #Genprex #Reqorsa

American Patient with Advanced Lung Cancer Stabilized by Immunotherapy in China A groundbreaking immunotherapy treatment in China has successfully stabilized an American patient with advanced lung cancer, showcasing innovations in cancer care.

American Patient with Advanced Lung Cancer Stabilized by Immunotherapy in China #China #Shanghai #Immunotherapy #Lung_Cancer #Jiahui_International

Revolutionary AI Tool Enhances Predictions for Lung Cancer Immunotherapy Responses A new AI radiology tool from Picture Health accurately predicts lung cancer patients' responses to immunotherapy by analyzing tumor blood vessel patterns.

Revolutionary AI Tool Enhances Predictions for Lung Cancer Immunotherapy Responses #USA #Cleveland #Immunotherapy #Lung_Cancer #Picture_Health

Innovative Immunotherapy Treatment in China Stabilizes U.S. Lung Cancer Patient A groundbreaking immunotherapy treatment in China has stabilized an American patient suffering from advanced lung cancer and Parkinson's disease, paving the way for new cancer care options.

Innovative Immunotherapy Treatment in China Stabilizes U.S. Lung Cancer Patient #China #Shanghai #Immunotherapy #Lung_Cancer #Jiahui_Center

A New Day-Use Surgery Option for Early Lung Cancer in Tokyo Discover the innovative day-surgery approach for early-stage lung cancer at the Tokyo Nihonbashi Clinic, minimizing patient burden while maximizing efficiency.

A New Day-Use Surgery Option for Early Lung Cancer in Tokyo #Japan #Tokyo #Lung_Cancer #Nihonbashi_Clinic #Day_Surgery

Innovative Immunotherapy Treatment Stabilizes US Patient with Advanced Lung Cancer in China A groundbreaking immunotherapy has stabilized a US patient suffering from advanced non-small cell lung cancer at Jiahui International Cancer Center in Shanghai.

Innovative Immunotherapy Treatment Stabilizes US Patient with Advanced Lung Cancer in China #China #Shanghai #Immunotherapy #Lung_Cancer #Jiahui_Center

Innovative Immunotherapy Provides Hope for U.S. Lung Cancer Patient in China A U.S. man with advanced lung cancer finds stabilization through groundbreaking immunotherapy at Jiahui International Cancer Center, China.

Innovative Immunotherapy Provides Hope for U.S. Lung Cancer Patient in China #China #Shanghai #Immunotherapy #Lung_Cancer #Jiahui_Hospital

U.S. Patient Overcomes Advanced Lung Cancer with New Immunotherapy in China A groundbreaking case highlights how a U.S. lung cancer patient found new hope through innovative immunotherapy at Jiahui International Cancer Center in Shanghai.

U.S. Patient Overcomes Advanced Lung Cancer with New Immunotherapy in China #China #Shanghai #Ivonescimab #Lung_Cancer #Jiahui_Cancer_Center

Optellum Expands AI Lung Nodule Solution by Securing TGA Approval in Australia Optellum has received TGA approval for its AI-based Virtual Nodule Clinic, enhancing lung cancer detection capabilities in Australia.

Optellum Expands AI Lung Nodule Solution by Securing TGA Approval in Australia #Oxford #Australia #Lung_Cancer #AI_Solution #Optellum

Lung Cancer Research Foundation and AstraZeneca Collaborate on Small Cell Lung Cancer Grants The Lung Cancer Research Foundation, in collaboration with AstraZeneca, unveils grants focused on advancing treatments for small cell lung cancer.

Lung Cancer Research Foundation and AstraZeneca Collaborate on Small Cell Lung Cancer Grants #United_States #New_York #AstraZeneca #Research_Grants #Lung_Cancer

LEADOPTIK Achieves Groundbreaking Milestone with First Human Use of LIA™ System LEADOPTIK has successfully conducted the first human use of its LIA™ System, a significant advancement in lung biopsy technology aimed at improving diagnostic accuracy.

LEADOPTIK Achieves Groundbreaking Milestone with First Human Use of LIA™ System #United_States #San_Jose #Lung_Cancer #LEADOPTIK #LIA™_System

For affordable #lung_cancer treatment in #Varanasi, contact Dr. Swapnil Patel at Upkar Super-Speciality Hospital & Cancer Institute. Call 81880 88515
drswapnilpatel.com

#LungCancerTreatmentVaranasi #CancerSurgeonVaranasi

NHS and Optellum Partner to Revolutionize Lung Cancer Diagnostics with AI and Robotics Optellum collaborates with NHS to streamline lung cancer diagnostics using AI-driven risk assessment and robotic technology, enhancing early detection and accuracy.

NHS and Optellum Partner to Revolutionize Lung Cancer Diagnostics with AI and Robotics #AI #United_Kingdom #Oxford #Lung_Cancer #Optellum

CancerIQ and Azra AI Unite to Revolutionize Lung Cancer Screening Programs CancerIQ and Azra AI collaborate to enhance lung cancer screening through targeted patient engagement and AI-driven imaging technology, improving early detection.

CancerIQ and Azra AI Unite to Revolutionize Lung Cancer Screening Programs #United_States #Chicago #Lung_Cancer #CancerIQ #Azra_AI

Exploring the Mechanisms of Lung Cancer Drug Resistance Through Protein Structure Recent research from Kanazawa University unveils how lung cancer drugs alter protein structures contributing to drug resistance. Significant insights for future therapies emerge.

Exploring the Mechanisms of Lung Cancer Drug Resistance Through Protein Structure #Japan #Lung_Cancer #Kanazawa_University #Kanazawa #ALK_Inhibitors

LUNGevity and Rising Tide Foundation Unite to Combat Lung Cancer Challenges LUNGevity and Rising Tide Foundation have launched a research initiative to address significant lung cancer challenges, focusing on drug resistance and recurrence.

LUNGevity and Rising Tide Foundation Unite to Combat Lung Cancer Challenges #USA #Washington #Lung_Cancer #LUNGevity #Rising_Tide_Foundation

LUNGevity Foundation Opens Applications for 2026 Research Grants to Advance Lung Cancer Care The LUNGevity Foundation is accepting applications for 2026 research grants aimed at revolutionizing lung cancer detection and treatment methods, with a focus on health equity.

LUNGevity Foundation Opens Applications for 2026 Research Grants to Advance Lung Cancer Care #United_States #Washington #Research_Grants #Lung_Cancer #LUNGevity

New Research Grant Opportunity for Lung Cancer Studies on Air Pollution Effects The Lung Cancer Research Foundation and OUCH-I launch a research grant to study air pollution's impact on lung cancer, inviting proposals until June 2026.

New Research Grant Opportunity for Lung Cancer Studies on Air Pollution Effects #USA #New_York #Lung_Cancer #Air_Pollution #Research_Grant

Nuvalent Marks Progress in OnTarget 2026 Operating Plan with New Milestones Nuvalent, Inc. highlights key milestones in its OnTarget 2026 plan, including FDA approval for zidesamtinib aimed at lung cancer treatment.

Nuvalent Marks Progress in OnTarget 2026 Operating Plan with New Milestones #United_States #Cambridge #Nuvalent #Lung_Cancer #zidesamtinib

Former NFL Stars Partner with CDC for Lung Cancer Awareness Initiative The NFL Alumni and CDC collaborate on the 'GEAR UP Against Cancer' campaign to boost lung cancer screening awareness and support.

Former NFL Stars Partner with CDC for Lung Cancer Awareness Initiative #United_States #New_York #CDC #Lung_Cancer #NFL_Alumni

BillionToOne Introduces Northstar Select® for Advanced Lung Cancer Study in Japan BillionToOne announces the inclusion of Northstar Select® as a liquid biopsy test in a major lung cancer study in Japan, enhancing patient treatment options.

BillionToOne Introduces Northstar Select® for Advanced Lung Cancer Study in Japan #Japan #Lung_Cancer #BillionToOne #Kashiwa #Northstar_Select